IONIQ Sciences (formerly known as ProLung) is a company that develops, manufactures, and sells non-invasive medical technology to aid in the early detection and diagnosis of lung cancer. It uses precision proprietary volume-averaging bioconductance technology to measure the difference in conductivity between malignant and benign lung tissue. The data is analyzed to produce a personalized and predictive score indicating the likelihood of malignancy in the lungs.